| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8815821 | Journal of Affective Disorders | 2018 | 36 Pages |
Abstract
As is the case for other antipsychotics, definitive evidence on aripiprazole reproductive safety is lacking, but newer safety data are relatively reassuring. In many cases, the potential benefits of aripiprazole for patients with bipolar disorder or schizophrenia outweigh the potential risks.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
A. Cuomo, A. Goracci, A. Fagiolini,